Funder: Breakthrough T1D
Due Dates: Rolling (inquiries accepted year-round for IDDP mechanism)
Funding Amounts: Typically up to $3,000,000 total over 3 years for clinical trials; amount and duration may vary by project scope and negotiation.
Summary: Supports for-profit organizations advancing research and development of therapies with commercial potential in priority areas of type 1 diabetes, including through matched funding and industry-academic collaboration.
Key Information: Applicants must contact Breakthrough T1D before submitting an LOI; indirect costs are not permitted on IDDP awards.